Management Change21 Jul 2026, 10:01 am
AstraZeneca India CFO Bhavana Agrawal Resigns for Regional Role
AI Summary
AstraZeneca Pharma India Ltd announced that Ms. Bhavana Agrawal, Executive Director and Chief Financial Officer (CFO), has resigned from her position. Her resignation is effective from the close of business hours on August 31, 2026. This change is due to her appointment to a regional role within the broader AstraZeneca Group. The company has provided the necessary disclosures as per SEBI regulations, including details of the resignation and her shareholding (NIL).
Key Highlights
- CFO Bhavana Agrawal resigns effective August 31, 2026.
- Reason for resignation is a regional role within AstraZeneca Group.
- No shareholding in the company by the resigning CFO.
- Disclosure made as per SEBI Listing Obligations and Disclosure Requirements Regulations.
Price Impact
More from ASTRAZEN